Linezolid vs. vancomycin/oxacillin/dicloxacillin in the treatment of catheter-related Gram-positive bloodstream infections

Trial Profile

Linezolid vs. vancomycin/oxacillin/dicloxacillin in the treatment of catheter-related Gram-positive bloodstream infections

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Sep 2014

At a glance

  • Drugs Dicloxacillin; Linezolid; Linezolid; Oxacillin; Vancomycin
  • Indications Bacteraemia; Catheter infections; Gram-positive infections
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 15 Sep 2009 Actual number of patients changed from 726 to 739 as reported by ClinicalTrials.gov.
    • 20 Sep 2007 Results reported at ICAAC 2007.
    • 01 Sep 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top